Jacek Jerzy Jozwiak
YOU?
Author Swipe
View article: The European Program for Prevention (EPP) – Implementing Proven Preventing Measures Now!
The European Program for Prevention (EPP) – Implementing Proven Preventing Measures Now! Open
Cardiovascular diseases (CVDs) remain a leading global cause of mortality and disability, with significant disparities observed across countries. This is particularly true in Central and Eastern Europe (CEE), where populations are primaril…
View article: The burden of diseases, injuries, and risk factors by voivodship in Poland, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
The burden of diseases, injuries, and risk factors by voivodship in Poland, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Open
Gates Foundation.
View article: SCORE2 charts assign a different risk category than the underlying model in a large portion of Polish primary care patients
SCORE2 charts assign a different risk category than the underlying model in a large portion of Polish primary care patients Open
Aims This study aims to compare the estimates provided by the SCORE2/SCORE2-OP charts with the estimates obtained by using SCORE2 and SCORE2-OP risk model equations. Methods and results Patients were recruited from 16 major Polish administ…
View article: Model for End-Stage Liver Disease Excluding INR Is Associated with Poor Prognosis in Elderly Patients with Decompensated Heart Failure
Model for End-Stage Liver Disease Excluding INR Is Associated with Poor Prognosis in Elderly Patients with Decompensated Heart Failure Open
Introduction: Heart failure (HF) remains a leading cause of morbidity and hospitalization among elderly patients. Therefore, identifying reliable prognostic indicators is crucial for improving clinical outcomes in this population. The aim …
View article: A 360° Perspective on Cardiovascular Prevention: the International Lipid Expert Panel SiMple tIps for the heaLthy hEart (ILEP-SMILE)
A 360° Perspective on Cardiovascular Prevention: the International Lipid Expert Panel SiMple tIps for the heaLthy hEart (ILEP-SMILE) Open
Despite decades of research into lifestyle factors and medications, we still cannot effectively prevent the occurrence of ASCVD and its complications. Yet, only a small percentage of the healthcare budget is allocated to prevention, and on…
View article: Correction to “Impact of surrogates for insulin resistance on mortality and life expectancy in primary care: a nationwide cross-sectional study with registry linkage (LIPIDOGRAM2015)” [The Lancet Regional Health – Europe 49 (2025) 101182]
Correction to “Impact of surrogates for insulin resistance on mortality and life expectancy in primary care: a nationwide cross-sectional study with registry linkage (LIPIDOGRAM2015)” [The Lancet Regional Health – Europe 49 (2025) 101182] Open
[This corrects the article DOI: 10.1016/j.lanepe.2024.101182.].
View article: Rosuvastatin-Based Combination Treatment with Acetylsalicylic Acid or Ezetimibe in the Management of Patients at High and Very High Cardiovascular Risk. Expert Opinion Paper of the Polish Lipid Association 2025.
Rosuvastatin-Based Combination Treatment with Acetylsalicylic Acid or Ezetimibe in the Management of Patients at High and Very High Cardiovascular Risk. Expert Opinion Paper of the Polish Lipid Association 2025. Open
Lipid disorders are the most common risk factor for ASCVD in Poland, where it is responsible for up to 200,000 deaths/year, with the number of MI and strokes reaching 80,000 annually and 25% of people dying within 3 years after MI. The lev…
View article: Incidence of Dementias, Socio-Economic Correlates and Policy Implications: A Machine Learning Approach Based on the GBD Study 2021 for the European Union
Incidence of Dementias, Socio-Economic Correlates and Policy Implications: A Machine Learning Approach Based on the GBD Study 2021 for the European Union Open
View article: Combination of sST2/LVMI Ratio and Modified MELD Scores Predicts Mortality in End-Stage Heart Failure
Combination of sST2/LVMI Ratio and Modified MELD Scores Predicts Mortality in End-Stage Heart Failure Open
Biomarkers are critical for heart failure (HF) management by facilitating risk stratification, therapeutic decision-making, and monitoring treatment response. This prospective, single-center study aimed to assess predictors of death during…
View article: The Prevention Opportunities of Retinopathy in Diabetic Patients - the Position Paper endorsed by the Polish Lipid Association.
The Prevention Opportunities of Retinopathy in Diabetic Patients - the Position Paper endorsed by the Polish Lipid Association. Open
CVD prevention does not only mean effective fight against the existing cardiovascular risk factors, but also against their complications, including micro- and macrovascular ones. In relation to obesity, prediabetes and diabetes, we recogni…
View article: Impact of surrogates for insulin resistance on mortality and life expectancy in primary care: a nationwide cross-sectional study with registry linkage (LIPIDOGRAM2015)
Impact of surrogates for insulin resistance on mortality and life expectancy in primary care: a nationwide cross-sectional study with registry linkage (LIPIDOGRAM2015) Open
Polish Lipid Association, College of Family Physician in Poland, Valeant in Poland.
View article: Combination of the Modified Models for End-Stage Liver Disease and sST2/LVMI Ratio Predicts Mortality in the Patients with Advanced Heart Failure
Combination of the Modified Models for End-Stage Liver Disease and sST2/LVMI Ratio Predicts Mortality in the Patients with Advanced Heart Failure Open
Biomarkers in heart failure (HF) management are critical for enhancing diagnostic accuracy, monitoring therapeutic response and assessing the risk of death. The aim of the study was to assess risk factors for one-year mortality in patients…
View article: 2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP) Open
Atherosclerotic cardiovascular disease (ASCVD) and consequent acute coronary syndromes (ACS) are substantial contributors to morbidity and mortality across Europe. Fortunately, as much as two thirds of this disease's burden is modifiable, …
View article: Telomere length across the spectrum of metabolic health – an analysis from the LIPIDOGEN2015 study
Telomere length across the spectrum of metabolic health – an analysis from the LIPIDOGEN2015 study Open
Introduction Background: Telomere length is a cellular aging marker and correlates with various cardiovascular disease (CVD) risk factors. The current study assessed the association between obesity, metabolic syndrome (MetS), and telomere …
View article: Risk of adverse cardiovascular events based on common genetic variants in 8-year follow-up of the LIPIDOGEN2015 population using the polygenic risk score (PRS) - study design and methodology.
Risk of adverse cardiovascular events based on common genetic variants in 8-year follow-up of the LIPIDOGEN2015 population using the polygenic risk score (PRS) - study design and methodology. Open
Introduction Classical risk factors such as hypertension, hypercholesterolemia, pre-diabetes, diabetes and obesity can predict adverse cardiovascular events, but they are less prognostic in patients age <60 years. Polygenic risk scores (PR…
View article: Ceruloplasmin and Lipofuscin Serum Concentrations Are Associated with Presence of Hypertrophic Cardiomyopathy
Ceruloplasmin and Lipofuscin Serum Concentrations Are Associated with Presence of Hypertrophic Cardiomyopathy Open
Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species and cells’ ability to neutralize them by antioxidant systems. The role of oxidative stress in hypertrophic cardiomyopathy (HCM) is not ful…
View article: The Critical Role of Community Pharmacists in Blood Pressure Monitoring
The Critical Role of Community Pharmacists in Blood Pressure Monitoring Open
Arterial hypertension is the most important modifiable risk factor for cardiovascular morbidity and mortality. In some countries, pharmacists' patient-centered approach has become a common practice, and their role in supporting the managem…
View article: Phenotypes of Polish primary care patients using hierarchical clustering: Exploring the risk of mortality in the <scp>LIPIDOGEN2015</scp> study cohort
Phenotypes of Polish primary care patients using hierarchical clustering: Exploring the risk of mortality in the <span>LIPIDOGEN2015</span> study cohort Open
Background Comorbidities in primary care do not occur in isolation but tend to cluster together causing various clinically complex phenotypes. This study aimed to distinguish phenotype clusters and identify the risks of all‐cause mortality…
View article: Association between Lp(a) and T2D: a Mendelian randomization study
Association between Lp(a) and T2D: a Mendelian randomization study Open
Introduction Blood lipoprotein(a) (Lp(a)) levels have been observed to be inversely correlated with type 2 diabetes (T2D). In this Mendelian randomization (MR) study, the causal impact of genetically predicted Lp(a) on T2D was assessed. Me…
View article: May Measurement Month 2021: an analysis of blood pressure screening results from Poland
May Measurement Month 2021: an analysis of blood pressure screening results from Poland Open
May Measurement Month 2021 (MMM21) is the fourth edition of the global initiative in Poland initiated by the International Society of Hypertension (ISH) and aimed at raising awareness of hypertension and the need for blood pressure (BP) sc…
View article: 2024 Guidelines of the Polish Society of Laboratory Diagnostics and the Polish Lipid Association on laboratory diagnostics of lipid metabolism disorders.
2024 Guidelines of the Polish Society of Laboratory Diagnostics and the Polish Lipid Association on laboratory diagnostics of lipid metabolism disorders. Open
Lipid disorders are the most common (even 70%) and worst monitored cardiovascular risk factor (only 1/4 of patients in Poland and CEE countries are on the LDL-C goal). In order to improve this the clear and easy to implement diagnostic cri…
View article: Burden of Stroke in Europe: An Analysis of the Global Burden of Disease Study Findings From 2010 to 2019
Burden of Stroke in Europe: An Analysis of the Global Burden of Disease Study Findings From 2010 to 2019 Open
BACKGROUND: While most European Regions perform well in global comparisons, large discrepancies within stroke epidemiological parameters exist across Europe. The objective of this analysis was to evaluate the stroke burden across European …
View article: Association of body mass index and long-term mortality in patients from nationwide LIPIDOGRAM 2004–2015 cohort studies: no obesity paradox?
Association of body mass index and long-term mortality in patients from nationwide LIPIDOGRAM 2004–2015 cohort studies: no obesity paradox? Open
View article: Genetically determined lipoprotein(a) levels do not cause an increased risk of preeclampsia - a two-sample Mendelian randomization study
Genetically determined lipoprotein(a) levels do not cause an increased risk of preeclampsia - a two-sample Mendelian randomization study Open
Introduction High blood levels of lipoprotein(a) [Lp(a)] were suggested to increase the risk of preeclampsia. Because excessive coagulation is involved in preeclampsia and Lp(a) is a known pro-coagulative protein, the hypothesis that Lp(a)…
View article: Development and validation of risk score for patients in primary care setting in Poland
Development and validation of risk score for patients in primary care setting in Poland Open
Background Suitable, optimal risk prediction in primary care is still a large challenge. Current tools enable the creation of risk scales based on data for specific populations, which can be a large support to recognized risk scales used i…
View article: Lipoprotein(a) is not a causal factor for the development of diabetes - a two-sample Mendelian randomization study
Lipoprotein(a) is not a causal factor for the development of diabetes - a two-sample Mendelian randomization study Open
Introduction The association between lipoprotein(a) [Lp(a)] and coronary artery disease is well known. Nevertheless, because physiological function of Lp(a) is not well understood, it is not clear what sort of adverse effects therapies aim…
View article: Global, regional, and national burden of spinal cord injury, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Global, regional, and national burden of spinal cord injury, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 Open
Bill & Melinda Gates Foundation.
View article: Global burden of peripheral artery disease and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Global burden of peripheral artery disease and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 Open
View article: Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019
Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019 Open
View article: Global blood pressure screening during the COVID-19 pandemic: results from the May Measurement Month 2021 campaign
Global blood pressure screening during the COVID-19 pandemic: results from the May Measurement Month 2021 campaign Open
Background: Raised blood pressure (BP) remains the biggest risk factor contributing to the global burden of disease and mortality, despite the COVID-19 pandemic. May Measurement Month (MMM), an annual global screening campaign aims to high…